MATRIA Health Technologies

What MATRIA Health Technologies does

MATRIA Health Technologies is a privately held French MedTech startup founded in 2015 (originally as HEMOSQUID and rebranded in 2024) and headquartered in Saint-Martin-d'Hères, in the Grenoble medical-device cluster. The company is developing the ILITEE medical device, a vacuum-based system that creates negative pressure to stimulate and amplify physiologic contractions of the uterus, with the goal of controlling postpartum hemorrhage (PPH) — particularly uterine atony, which accounts for approximately 80% of PPH cases. The technology is grounded in a large patent portfolio (filed/pending) covering vacuum hemostasis, and the device design has been co-developed with an advisory network of obstetricians contributing to prototyping optimization.

The company's core technology is purely mechanical/physiological — there are no software, AI/ML, or digital-health components disclosed — and ILITEE is positioned as the sole product offering. MATRIA is currently pre-revenue and pre-commercialization: as of 2025 it is finalizing preclinical tests and preparing clinical investigations, and no pricing model, distribution agreements, or named customers have been disclosed. The intended go-to-market is direct sales of the device to hospitals and healthcare facilities globally, but current operating geography is limited to EMEA/France.

MATRIA is founder-owned and operated under a French SAS (Société par Actions Simplifiée) structure, with no institutional investors, parent company, M&A activity, or funding rounds disclosed in the input data. The leadership team is led by CEO/CTO Franck OTT (PhD, engineer specialized in medical devices), President Stéphane Lavallée, and Project Manager Ethel Cappelletti (biomedical engineer), supported by a small functional team covering legal, IP, QARA, HR, IT, and administration. The company addresses a large unmet need — roughly 14 million women experience PPH annually and approximately 70,000 die each year — but is still several regulatory and commercial milestones away from revenue.

Name

MATRIA Health Technologies

Legal name

MATRIA HEALTH TECHNOLOGIES SAS

Website

https://matria-health-technologies.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

MATRIA Health Technologies is a French MedTech startup developing the ILITEE device, a vacuum-based system that controls postpartum hemorrhage by stimulating uterine contractions. The company is pre-commercial, targeting hospitals and obstetric care providers globally with a focus on uterine atony.

Ownership category

akta.pro rank

Headquarters

HQ city

Saint-martin-d'heres

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain

Distribution channels1 record

Marketing channels1 record

Core offering

MATRIA Health Technologies develops the ILITEE medical device, an innovative vacuum-based system that creates negative pressure to stimulate and amplify the natural contractions of the uterus in order to immediately and efficiently control postpartum hemorrhage (PPH). The device is designed for use by obstetricians and maternal healthcare professionals in hospitals and birthing settings, with a particular focus on uterine atony, which accounts for 80% of PPH cases. The product is currently in pre-clinical/pre-commercialization stage, preparing for clinical investigations.

Product overview

MATRIA Health Technologies is a French MedTech startup that offers a single unified product: the ILITEE medical device. Originally developed under the HEMOSQUID brand, ILITEE is an innovative solution for treating postpartum hemorrhage by using vacuum-induced negative pressure to stimulate uterine contractions. The company rebranded to MATRIA Health Technologies in 2024 to reflect growing international interest in their medical solution.

Differentiator

Problem solved

Functional benefit

Brands

• ILITEE: Innovative medical device that creates negative pressure with vacuum to stimulate and amplify physiologic contractions of the uterus for postpartum hemorrhage control.

Products and services

• ILITEE Medical Device The ILITEE medical device creates negative pressure with vacuum to stimulate and amplify physiologic contractions of the uterus, providing immediate and efficient control of postpartum hemorrhage (PPH). It targets uterine atony — the cause of 80% of PPH cases — by strangulating the arteries that fed the placenta, naturally stopping bleeding. Designed for use by obstetricians and maternal healthcare professionals in hospitals and birthing settings.

Quantifiable outcome

• ILITEE creates negative pressure with vacuum to stimulate and amplify physiologic contractions of the uterus

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core.

• Medical Device Experts NetworkcoreOthersMatria Health Technologies relies on a network of medical device experts for development and commercialization of the ILITEE device. Obstetricians have been assisting the team in designing the solution.
• Obstetricians (Medical Advisory)coreStrategic or Co-development PartnerNumerous obstetricians believe in the project and are assisting the team in designing a perfect solution for postpartum hemorrhage control. They contribute to prototyping optimization for fast and safe treatment.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Organon (Alydia Health / Jada System): Organon acquired Alydia Health, developer of the Jada System, an intrauterine vacuum-induced negative pressure device for postpartum hemorrhage — directly comparable mechanism, indication, and use setting to MATRIA's ILITEE.
• Cook Medical (Bakri balloon): Cook Medical's Bakri balloon is one of the most established mechanical PPH interventions globally and represents the current standard-of-care device that ILITEE must displace or complement in labor and delivery suites.

Broad incumbents

• CooperSurgical: CooperSurgical is a leading women's health medical device company offering a broad portfolio in obstetrics, fertility, and gynecology; a likely strategic acquirer or partner for emerging PPH device assets like MATRIA.
• Laborie (formerly Clinical Innovations): Laborie owns Clinical Innovations and other obstetric brands (e.g., Kiwi vacuum delivery systems), making it a relevant incumbent in the labor and delivery device space and a potential acquirer of ILITEE.
• Teleflex: Teleflex has a meaningful presence in obstetric and surgical devices, including uterine manipulators and hemostasis products, making it a comparable broad incumbent in the surgical/obstetric device category.
• Becton Dickinson (BD): BD is a diversified medical device manufacturer with significant exposure to women's health, obstetrics, and surgical hemostasis — a comparable large-cap medtech with adjacent product categories.
• Stryker: Stryker operates broadly across surgical and emergency care devices, including hemostasis and women's health adjacencies, making it a relevant large-cap comparable for surgical device commercialization pathways.

Emerging players

• Utah Medical Products: Utah Medical Products specializes in niche obstetrics and neonatal devices, making it a comparable focused women's-health medtech with overlapping customer base in labor and delivery.
• Inari Medical: Inari Medical commercializes catheter-based vacuum thrombectomy devices for venous thromboembolism — the closest mechanistic analog to a vacuum-based PPH device and a relevant emerging medtech peer.
• Penumbra: Penumbra develops catheter-based vacuum aspiration systems (e.g., Indigo, Lightning) used in vascular and surgical settings; the underlying aspiration technology and target OR/IR setting overlap with MATRIA's vacuum-hemostasis approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights6 records

Customer concentration

• Xx.com/matriahealthtech
• LinkedInlinkedin.com/company/matria-health-technologies

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MATRIA Health Technologies